SCHEMBL1959786

SCHEMBL1959786

OC1(c2ccc(Cl)nc2)CCCC1

nearest known ligand 0.41

Predicted protein targets (top 11)

geneUniProtsupporting neighboursconfidence
TRPA1 O75762 1/20 0.41
DRD2 P14416 1/20 0.39
NAPRT Q6XQN6 1/20 0.37
P2RX7 Q99572 5/20 0.37
PDE10A Q9Y233 1/20 0.36
OGA O60502 2/20 0.36
HRH3 Q9Y5N1 2/20 0.36
FPR2 P25090 1/20 0.35
ADRA2A P08913 1/20 0.35
ADRA2B P18089 1/20 0.35
ADRA2C P18825 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL19284042 0.98 TRPA1 (0.40) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL21848271 0.96 DRD2 (0.39) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL29695056 0.92 DRD2 (0.41) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL3602093 0.92 DRD2 (0.41) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL12558093 0.84 CDK4 (0.38) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL1750265 0.84 DRD2 (0.61) TRPA1DRD2NAPRTPDE10A
SCHEMBL19284003 0.84 OGA (0.40) TRPA1DRD2NAPRTP2RX7PDE10A
SCHEMBL31572560 0.79 WDR91 (0.40) TRPA1NAPRTPDE10AOGAADRA2A
SCHEMBL19283986 0.79 WDR91 (0.40) TRPA1NAPRTPDE10AOGAADRA2A
SCHEMBL18929479 0.78 ESR1 (0.38) DRD2OGAHRH3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 69 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3419972-B1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2023-07-26 EP disclosed
US-11612599-B2 Glycosidase inhibitors ASCENEURON SA (CH) 2023-03-28 US disclosed
EP-3419971-B1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2022-04-20 EP disclosed
EP-3419971-B1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2022-04-20 EP disclosed
US-20210186958-A1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2021-06-24 US disclosed
US-20210186958-A1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2021-06-24 US disclosed
US-10556902-B2 Glycosidase inhibitors ASCENEURON SA (CH) 2020-02-11 US disclosed
US-10556902-B2 Glycosidase inhibitors ASCENEURON SA (CH) 2020-02-11 US disclosed
US-20190055239-A1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2019-02-21 US disclosed
US-20190055239-A1 GLYCOSIDASE INHIBITORS ASCENEURON SA (CH) 2019-02-21 US disclosed
US-20080280915-A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines CORTEVA AGRISCIENCE LLC 2008-11-13 US disclosed
WO-2008057131-A1 HETEROARYL (SUBSTITUTED) ALKYL N-SUBSTITUTED SULFOXIMINES AS INSECTICIDES DOW AGROSCIENCES LLC (US) 2008-05-15 WO disclosed
WO-2008057131-A1 HETEROARYL (SUBSTITUTED) ALKYL N-SUBSTITUTED SULFOXIMINES AS INSECTICIDES DOW AGROSCIENCES LLC (US) 2008-05-15 WO disclosed
US-20080108666-A1 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides CORTEVA AGRISCIENCE LLC 2008-05-08 US disclosed
US-20080108666-A1 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides CORTEVA AGRISCIENCE LLC 2008-05-08 US disclosed
US-20080108666-A1 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides CORTEVA AGRISCIENCE LLC 2008-05-08 US disclosed
WO-2008030266-A2 INSECTICIDAL N-SUBSTITUTED (HETEROARYL)ALKYL SULFILMINES DOW AGROSCIENCES LLC (US) 2008-03-13 WO disclosed
WO-2008030266-A2 INSECTICIDAL N-SUBSTITUTED (HETEROARYL)ALKYL SULFILMINES DOW AGROSCIENCES LLC (US) 2008-03-13 WO disclosed
WO-2008021729-A2 COMPOSITIONS AND METHODS FOR TREATING, REDUCING, AMELIORATING, OR ALLEVIATING POSTERIOR-SEGMENT OPHTHALMIC DISEASES BAUSCH & LOMB INCORPORATED (US) 2008-02-21 WO disclosed
WO-2007118819-A2 NOVEL CRYSTALLINE COMPOUNDS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2007-10-25 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (6 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-11612599-B2 Glycosidase inhibitors ENGASE, GAA, GLA TRPA1 4819/4885DRD2 3906/4885NAPRT 337/4885
US-10556902-B2 Glycosidase inhibitors ENGASE, GAA, GLA TRPA1 4810/4885DRD2 3843/4885NAPRT 289/4885
US-20080280915-A1 Insecticidal n-substituted (heteroaryl)alkyl sulfilimines AANAT, GNMT, STS TRPA1 1472/4885DRD2 238/4885NAPRT 293/4885
US-20210186958-A1 GLYCOSIDASE INHIBITORS ENGASE, GAA, GLA TRPA1 4819/4885DRD2 3906/4885NAPRT 337/4885
US-20080108666-A1 Heteroaryl (substituted)alkyl N-substituted sulfoximines as insecticides STS, DDT, TST TRPA1 2623/4885DRD2 328/4885NAPRT 104/4885
US-20190055239-A1 GLYCOSIDASE INHIBITORS ENGASE, GAA, GLA TRPA1 4810/4885DRD2 3843/4885NAPRT 289/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.